Selective phosphodiesterase-4 inhibitors
Other names: PDE4
What are Selective phosphodiesterase-4 inhibitors?
Selective phosphodiesterase-4 inhibitors increase cyclic adenosine-3′,5′-monophosphate (cAMP) levels, resulting in a broad spectrum of anti-inflammatory effects in almost all inflammatory cells. Selective phosphodiesterase-4 inhibitors are used in the treatment of severe Chronic Obstructive Pulmonary Disease (COPD) to reduce the risk of COPD exacerbations. They are not bronchodilators and therefore not indicated for the relief of acute bronchospasm.
List of Selective phosphodiesterase-4 inhibitors
View by Generic | Brand
| Drug Name | Avg. Rating | Reviews |
|---|---|---|
| roflumilast topical (Pro) Brand names: Zoryve, Zoryve Foam |
52 reviews | |
| roflumilast systemic (Pro) Brand name: Daliresp |
72 reviews | |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
See also
Medical conditions treated or associated with selective phosphodiesterase-4 inhibitors:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.